Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in Persistent Diabetic Macular Edema
NCT01951066Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2013
- Primary completion
- Dec 2015
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozurdex in diabetic macular edema (DME), sponsored by Johns Hopkins University. Started Oct 2013; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01951066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951066.